STOCK TITAN

Arrive AI raises $250K in private stock offering

No brokerage, finder’s fee or placement-agent commission is payable in connection with the private placement.

(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Arrive AI Inc. completed a private investment in public equity (PIPE) on October 5, 2026, selling 384,615 common shares and a warrant to buy 384,615 shares for an aggregate purchase price of $250,000, or $0.65 per share and accompanying warrant. It received $250,000 gross before a $5,000 reimbursement of the purchaser’s legal and other offering expenses; net proceeds are intended for general working capital.

The warrant is immediately exercisable at $0.70 per share and expires October 5, 2031; cashless exercise yields a number of shares equal to the otherwise issuable number multiplied by 3.33. Exercise is generally subject to a 4.99% beneficial-ownership cap, adjustable up to 9.99%; an increase takes effect 61 days after notice. Arrive AI agreed to file a resale registration statement within 20 days after closing.

Arrive AI clarified that the shares and warrant were unregistered when issued in an exempt PIPE, correcting the press release’s “registered direct offering” description. The investor expressed interest in evaluating up to $10 million in additional financing, subject to market conditions, registration capacity, regulatory requirements, definitive documentation and company approval; there is no assurance it will be completed.

Insights

Analyzing...

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Common shares sold 384,615 shares Private placement completed October 5, 2026
Warrant shares 384,615 shares Shares issuable upon warrant exercise
Aggregate purchase price $250,000 Private placement
Purchase price $0.65 per share and accompanying warrant Private placement
Warrant exercise price $0.70 per share Common warrant
Beneficial-ownership limitation 4.99%, adjustable up to 9.99% Warrant exercise limitation
Cashless exercise multiplier 3.33 Applied to the number of shares otherwise issuable upon exercise
Additional financing under evaluation Up to $10 million Investor expressed interest in evaluating potential additional financing
PIPE financial
"private placement in public equity transaction (the “Private Placement” or “PIPE”)"
A PIPE (private investment in public equity) is a deal in which institutional or accredited investors buy shares or convertible securities directly from a publicly traded company, usually at a discount to the market price. Companies use PIPEs to raise money faster than through a traditional public offering; for existing shareholders they matter because the newly issued shares add to the share count and can dilute ownership.
cashless basis financial
"exercised, in whole or in part, on a cashless basis"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
beneficially own regulatory
"beneficially own more than 4.99% of the Company’s outstanding common stock"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
accredited investor regulatory
"Purchaser represented that it is an “accredited investor”"
An accredited investor is an individual or entity that meets certain financial criteria, such as having a high income or significant net worth, allowing them to invest in private or less regulated investment opportunities. This status matters because it grants access to investments that are often riskier or less available to the general public, reflecting a higher level of financial knowledge or resources.
Rule 506 of Regulation D regulatory
"Rule 506 of Regulation D promulgated thereunder"
Rule 506 of Regulation D is a U.S. Securities and Exchange Commission exemption that lets companies sell securities privately without registering them with the SEC, similar to a private party invitation rather than a public auction. It matters to investors because it determines how much information they’ll receive, who can buy (accredited vs. non-accredited), whether public advertising is allowed, and how easily the investment can be resold — all factors that affect risk, transparency and liquidity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did ARAI raise in the October 2026 PIPE?

Arrive AI received $250,000 in gross proceeds, before a $5,000 reimbursement of the purchaser’s legal expenses and other offering expenses payable by the company.

What warrant terms did ARAI agree to?

The warrant is immediately exercisable at $0.70 per share and expires October 5, 2031. Cashless exercise is permitted during its term, with the share amount calculated by multiplying the number otherwise issuable by 3.33.

What securities will ARAI register for resale?

Arrive AI agreed to file a Form S-3, or another form then available to the company, covering resale of the 384,615 shares and the maximum number of shares issuable under the warrant, within 20 days after the October 5, 2026 closing.

Was ARAI’s October 2026 investment a registered direct offering?

No. Arrive AI clarified that the shares and warrant were unregistered when issued and that the transaction was a PIPE exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001818274 0001818274 2026-10-05 2026-10-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event Reported): October 5, 2026

 

Arrive AI Inc.

(Exact Name of Registrant as Specified in Charter)

 

001-42645

(Commission File Number)

 

Delaware   85-0935006

(State or Other Jurisdiction

of Incorporation)

 

(I.R.S. Employer

Identification Number)

 

9100 Fall View Drive

Fishers, IN 46037

(Address of principal executive offices, with zip code)

 

(463) 270-0092

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   ARAI   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement

 

On October 5, 2026, Arrive AI Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a private placement in public equity transaction (the “Private Placement” or “PIPE”), (i) 384,615 shares of the Company’s common stock, par value $0.0002 per share (the “Shares”), and (ii) a common stock purchase warrant (the “Common Warrant”) to purchase 384,615 shares of common stock (the “Warrant Shares”), for an aggregate purchase price of $250,000. The purchase price was $0.65 per Share and accompanying Common Warrant. The Private Placement closed on October 5, 2026.

 

The Common Warrant is immediately exercisable at an exercise price of $0.70 per share and expires on October 5, 2031. The Common Warrant may also be exercised, in whole or in part, on a cashless basis at any time during its term, in which case the holder is entitled to receive a number of Warrant Shares equal to the number otherwise issuable upon exercise multiplied by 3.33, without payment of the exercise price. The Common Warrant generally may not be exercised to the extent the holder and its affiliates would beneficially own more than 4.99% of the Company’s outstanding common stock immediately after exercise. The holder may increase or decrease this limitation, provided that it may not exceed 9.99%, and any increase will not become effective until the 61st day after notice is delivered to the Company.

 

Under the Purchase Agreement, the Company is required to file with the Securities and Exchange Commission, within 20 days after the closing date, a registration statement on Form S-3 (or such other form as may then be available to the Company) covering the resale by the Purchaser of the Shares and the maximum number of Warrant Shares issuable upon exercise of the Common Warrant.

 

The Company intends to use the net proceeds from the Private Placement for general working capital purposes. No brokerage, finder’s fee or placement-agent commission is payable in connection with the Private Placement.

 

The foregoing descriptions of the Purchase Agreement and the Common Warrant do not purport to be complete and are qualified in their entirety by reference to the full text of the Purchase Agreement and the Common Warrant, copies of which are filed as Exhibits 10.1 and 4.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. The Shares, the Common Warrant and the Warrant Shares issuable upon exercise of the Common Warrant, were offered and sold, or will be issued, in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 of Regulation D promulgated thereunder. The Purchaser represented that it is an “accredited investor” as defined in Rule 501(a) of Regulation D or a “qualified institutional buyer” as defined in Rule 144A under the Securities Act. The offer and sale were made without any general solicitation or advertising. The Company received gross proceeds of $250,000 from the Private Placement, before deducting the $5,000 reimbursement of the Purchaser’s legal expenses and other offering expenses payable by the Company.

 

2

 

 

Item 7.01. Regulation FD Disclosure.

 

On October 6, 2026, the Company issued a press release announcing the Private Placement. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The press release characterized the Private Placement as a registered direct offering conducted pursuant to the Company’s effective shelf registration statement on Form S-3. The Company hereby clarifies that the Private Placement was a PIPE transaction exempt from registration under the Securities Act pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder. The Shares and the Common Warrant were not registered under the Securities Act when issued. As required by the Purchase Agreement, the Company has agreed to file with the Securities and Exchange Commission, within 20 days after the closing date, a registration statement on Form S-3 (or such other form as may then be available to the Company) covering the resale by the Purchaser of the Shares and the maximum number of Warrant Shares issuable upon exercise of the Common Warrant, as more fully described in the Purchase Agreement. Except for the foregoing correction, the information in the press release remains unchanged.

 

The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits

 

Exhibit No.   Description
4.1   Form of Common Stock Purchase Warrant, dated October 5, 2026.
10.1   Form of Securities Purchase Agreement, dated October 5, 2026.
99.1   Press Release, dated October 6, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ARRIVE AI, INC.
     
Date: October 9, 2026 By: /s/ Daniel S. O’Toole
    Daniel S. O’Toole
    Chief Executive Officer

 

4

 

 

Exhibit 99.1

 

Arrive AI (NASDAQ:ARAI) Announces $0.65 per Share Direct Investment at 213% Premium to Market; Institutional Investor Signals Interest in Up to $10 Million

 

Investor Completes a Direct Investment at $0.65 per Share – a Premium of More than 213% to Recent Trading Levels

 

The Investor Has Also Expressed Interest in Evaluating Up to $10 Million in Potential Additional Financing as Arrive AI Advances Its 2026 Growth Plan

 

INDIANAPOLIS, IN October 6, 2026 /ACCESSWIRE/ -- Arrive AI Inc. (NASDAQ:ARAI) (“Arrive AI” or the “Company”), a physical AI and autonomous logistics infrastructure company enabling drones, robots, autonomous mobile robots (AMRs), autonomous vehicles (AVs) and human couriers to securely exchange goods, today announced a premium-priced direct investment from a specialized private investment firm based in the United States.

 

The direct investment was priced at $0.65 per unit (each unit consisting of one share of common stock and one warrant), representing approximately a 213% premium to Arrive AI’s recent trading price of $0.2075 underscoring the investor’s confidence in the Company’s outlook and long-term growth potential. The financing also includes warrants exercisable at $0.70 per share, further aligning the transaction with potential future upside in Arrive AI’s common stock.

 

The investor has also expressed interest in evaluating additional financing transactions with Arrive AI of up to $10 Million, subject to market conditions, available registration capacity, regulatory requirements, definitive documentation, and Company approval. There can be no assurance that any additional financing will be completed, and any such transaction would be subject to negotiation and execution of definitive agreements on terms acceptable to both parties.

 

Premium-Priced Capital Reflects Outside Confidence During a Key Execution Year

 

Arrive AI believes the structure of this investment is notable because it was priced at a substantial premium to the Company’s recent market price. Management views the premium pricing, warrant structure, and additional financing interest as a constructive signal as Arrive AI continues executing against its 2026 commercial growth plan.

 

The investment was completed through a registered direct offering pursuant to the Company’s effective shelf registration statement on Form S-3. The initial investment amount was $250,000. Investors may review the terms and conditions of the offering and the warrants in the Company’s Current Report on Form 8-K which will be filed with the SEC.

 

“We believe this premium-priced investment sends an important signal at a pivotal time for Arrive AI,” said Piyush Phadke, Chief Financial Officer of Arrive AI. “A direct investment priced at a meaningful premium to our recent trading levels represents a strong vote of confidence in where we’re headed.”

 

About Arrive AI

 

Arrive AI (NASDAQ:ARAI) is building the infrastructure for autonomous logistics through a network of intelligent delivery endpoints that enable secure, asynchronous exchange of goods. The company’s platform supports drones, ground robotics, and human couriers, solving the “last inch of the last-mile” challenge across logistics, healthcare, and enterprise delivery.

 

Forward-Looking Statements

 

This news release and statements of Arrive AI’s management in connection with this release or related events may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events and expected business and financial performance and often include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “potential,” “will,” “should,” “could,” “would,” “optimistic,” or “may,” and similar expressions. These statements are based on information available as of the date of this release and reflect management’s current views and assumptions. They are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that may be beyond the company’s control. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release. With respect to any potential additional financing transactions, there can be no assurance such transactions will be completed on the terms described or at all. Potential investors should review Arrive AI’s Registration Statement and other filings, including risk factors, available at the U.S. Securities and Exchange Commission website at www.sec.gov. Arrive AI undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date of this release, except as required by law.

 

Media Contact

 

Tasha Jones, Marketing Communications Manager, Arrive AI, media@arriveai.com

 

Investor Contact

 

Alliance Advisors IR, ARAI.IR@allianceadvisors.com

 

SOURCE

 

Arrive AI, Inc.

 

 

 

Filing Exhibits & Attachments

6 documents

Keep reading